A Malaria Rapid Test (RDT) is a quick diagnostic blood test that checks for malaria antigen—proteins released by malaria parasites (Plasmodium species) into the bloodstream. Unlike a malaria blood smear (microscopy), which looks for parasites under a microscope, an RDT detects parasite antigens using a test strip (similar in concept to a home pregnancy test). Results are typically available within 15–30 minutes.

Most malaria RDTs detect one or more of the following antigens:

• HRP2 (Histidine-rich protein 2): commonly associated with Plasmodium falciparum, the species most linked to severe malaria.

• pLDH (parasite lactate dehydrogenase) and/or aldolase: may detect P. falciparum and/or non-falciparum malaria such as P. vivax, P. ovale, and P. malariae (depending on the brand/panel).

What the results mean (plain language):

• Positive: Malaria antigen was found, meaning you likely have an active malaria infection (or very recent infection). Your clinician may still order a blood smear to identify the exact species and estimate parasite level, which helps guide treatment.

• Negative: Malaria antigen was not detected. This makes malaria less likely, but it does not completely rule it out—especially early in infection, with low parasite levels, or if the test does not detect a specific species well. If symptoms and travel risk are high, repeat testing and/or microscopy is often recommended.

• Important limitations: Some P. falciparum strains have HRP2/HRP3 gene deletions that can cause false-negative HRP2-based tests. Also, HRP2 antigen can remain detectable after treatment, causing a positive result even when parasites are no longer present.

This test is widely used in urgent care, emergency settings, travel medicine, and clinics where immediate decisions are needed. It is a diagnostic tool and should be interpreted along with symptoms, travel/exposure history, and sometimes confirmatory testing.

A Malaria Rapid Test (RDT) is usually ordered when malaria is suspected and a fast answer is needed—especially because malaria can become serious quickly, particularly P. falciparum infection. Doctors often consider this test in anyone with fever and a possible exposure to malaria-carrying mosquitoes.

Common symptoms that prompt testing include:

• Fever (may be intermittent), chills, and sweating

• Headache, body aches, and unusual fatigue

• Nausea, vomiting, diarrhea, or abdominal pain

• Dizziness or weakness

• Yellowing of skin/eyes (jaundice) or dark urine

• Confusion, shortness of breath, chest discomfort, or severe illness (possible severe malaria—needs urgent evaluation)

Risk factors and situations where it’s commonly used:

• Recent travel to or residence in a malaria-endemic area (parts of sub-Saharan Africa, South and Southeast Asia, Central/South America, Oceania)

• Fever after travel—symptoms can start as soon as 7 days after exposure, but sometimes weeks to months later (especially with P. vivax or P. ovale)

• Incomplete or missed malaria prevention (chemoprophylaxis), or mosquito exposure without protection

• Pregnancy, childhood, older age, or immune compromise (higher risk of complications)

• Evaluation of a febrile illness when other causes (like influenza, COVID-19, or gastrointestinal infection) are also being considered

Why it’s done: The RDT helps quickly determine whether malaria antigens are present so treatment can be started promptly if needed. In many settings, clinicians will still request a malaria microscopy smear and/or PCR to confirm the diagnosis, identify the species, and check parasite density—especially if the RDT is negative but suspicion remains high, or if severe malaria is possible.

• Malaria (Plasmodium infection)

• Plasmodium falciparum malaria (including severe malaria)

• Plasmodium vivax malaria

• Plasmodium ovale malaria

• Plasmodium malariae malaria

• Mixed-species malaria infection